Kevin C.J. Yuen

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 2.8K citations · Full text

Metabolic Syndrome, Diabetes Management, Cardiovascular Disease +9

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 600 citations · Full text

Metabolic Syndrome, Diabetes Management, Urology +10

American Association of Clinical Endocrinologists and American College of Endocrinology Guidelines for Management of Growth Hormone Deficiency in Adults and Patients Transitioning from Pediatric to Adult Care

Kevin C.J. Yuen, Beverly M. K. Biller, Sally Radovick et al. · Endocrine Practice · 2019 · 266 citations

Growth Hormone, American Association, Human Growth +8

Novel Use of Glucagon in a Closed-Loop System for Prevention of Hypoglycemia in Type 1 Diabetes

Jessica R. Castle, J. Michael Engle, Joseph El Youssef et al. · Diabetes Care · 2010 · 230 citations · Full text

American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for Growth Hormone Use in Growth Hormone-Deficient Adults and Transition Patients – 2009 Update

David M. Cook, Kevin C.J. Yuen, Beverly M. K. Biller et al. · Endocrine Practice · 2009 · 180 citations

Growth Hormone, American Association, Human Growth +8